Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-02-06 | Reverse | 1:5 |
| 2026-02-05 | Reverse | 1:5 |
| 2024-11-21 | Reverse | 1:4 |
| 2024-09-09 | Reverse | 1:6 |
| 2023-07-03 | Reverse | 1:10 |
PRF Technologies Ltd. is an Israeli clinical-stage pharma company developing PRF-110, a long-acting post-surgical pain relief solution currently in Phase 3 trials for bunionectomy and hernia repair.

PRF Technologies' AI-driven solar analytics service offers technical due diligence for utility-scale solar plants, highlighting its focus on renewable energy and recent commercial agreements.
Overall rating: B
| PEER | PRICE | |
|---|---|---|
VRAX | $3.19 | COMPARE |
UPC | $5.30 | COMPARE |
ELAB | $6.66 | COMPARE |
NCEL | $3.26 | COMPARE |
DRMA | $1.42 | COMPARE |
ATXI | $0.26 | COMPARE |
NKGN | $0.01 | COMPARE |
XRTX | $2.04 | COMPARE |